Orbotech Ltd.

Key Executives: Raanan Cohen President & CEO  Amichai Steinberg COO  Investor Relations: Adrian Auman   Phone: 972-8-942-3560   Web Site: http://www.orbotech.com Email: adrian-a@orbotech.com Exchange: NASDAQ  Symbol: ORBK  Year Listed: 1984  NASDAQ Trading Main Indexes: NASDAQ Israel, NASDAQ Global Select Market Industry: Electronics, Optics Year Established: 1981 # of Employees: 1,602 Research Coverage: Avian Securities, Barclays Capital, Chardan Capital Markets, Needham & Co., Oppenheimer & Co., RBC Capital Markets Auditor: Kesselman & Kesselman (member of PricewaterhouseCoopers) Law Firm: Cravath, Swaine & Moore LLP, Tulchinsky, Stern & Co. Office Address: Sderot Hasanhedrin, PO Box 215, Yavne 81101 Israel Telephone: 972-8-942-3533 Fax: 972-8-943-8769

  Orbotech designs, develops, manufactures, markets and services yield-enhancing and production solutions for specialized applications in the supply chain of the electronics industry. Orbotech's products include automated optical inspection (AOI), production and process control systems for printed circuit boards (PCBs) and AOI, and test and repair systems for flat panel displays (FPDs). The company also markets computer-aided manufacturing (CAM) and engineering solutions for PCB production.
  Through its subsidiary, Orbograph Ltd., the company develops and markets character recognition solutions to banks and other financial institutions and has developed a proprietary technology for Web-based, location-independent data entry for check processing and forms processing.
  Through its subsidiaries, Orbotech Medical Denmark A/S and Orbotech Medical Solutions Ltd., the company is engaged in the research and development, manufacture and sale of specialized products for applications in medical nuclear imaging. In October 2010, the company agreed to sell the assets of Orbotech Medical Solutions Ltd. to GE Company (NYSE: GE). The transaction closed in February 2011. In April 2011, the company conditionally agreed to a managment buyout of Orbotech Medical Denmark A/S. As such, during 2010, Orbotech Medical Solutions Ltd. and Orbotech Medical Denmark A/S were reclassified as discontinued operations.  
  More than one quarter of Orbotech’s employees are scientists and engineers, who integrate their multi-disciplinary knowledge, talents and skills to develop and provide sophisticated solutions and technologies designed to meet long-term customer needs.
  The company maintains its headquarters, as well as substantial research, development and manufacturing facilities in Israel, and more than 35 offices worldwide. Orbotech's extensive network of marketing, sales and customer support teams throughout North America, Europe, the Pacific Rim, China and Japan delivers knowledge and expertise directly to customers the world over.

All Announcements